The AP-2 family of transcription factors (AP-2a, AP-2b and AP-2g) is temporally and spatially regulated in mammals and has also been implicated in oncogenesis. Here we report the isolation of genomic and cDNA clones encoding the Drosophila homologue of AP-2, designated DAP-2. The predicted amino acid sequence exhibits 42 ± 45% overall identity with the vertebrate AP-2 proteins. A sequence of 107 amino acids within the DNA binding and dimerization domain of the vertebrate AP-2 proteins is highly conserved (90 ± 92%) with the DAP-2 homologue. An in vitro translation product of DAP-2 cDNA binds speci®cally to AP-2 consensus binding sites. DAP-2 was also shown to be functionally conserved in vivo because transient transfection of a DAP-2 expression plasmid activated transcription through AP-2 binding sites in both mammalian and Drosophila cell lines. DAP-2 is expressed during early embryogenesis and DAP-2 transcripts are also detected in the adult. Whole-mount in situ hybridizations demonstrated that DAP-2 is expressed initially at stage 9 of Drosophila embryonic development and that DAP-2 transcripts are detected in regions of the brain, eyeantennal disc, optical lobe, antenno-maxillary complex, and in a subset of cells of the ventral nerve cord. The cloning of DAP-2 and the identi®cation of the DAP-2 expression pattern during embryogenesis provides a starting point to address the function of AP-2 during dierentiation and development in a well understood model system.
Introduction
The family of AP-2 proteins encompasses three dierent isoforms of AP-2 transcription factors, AP2a, AP-2b, and AP-2g (Williams et al., 1988; Moser et al., 1995; Oulad Abdelghani et al., 1996) . Additionally, a number of splice variants exist (Buettner et al., 1993; Meier et al., 1995) that generate more diversity in AP-2 isoforms. The three AP-2 proteins share common structural features and exhibit an overall identity between 63% and 66%. The N-terminal half of all three AP-2 proteins contains a high amount of prolines and glutamines and is responsible for the transcriptional activation (Williams and Tjian, 1991) , yet the Nterminal homology is low (51 ± 60%). DNA binding and dimerization are mediated by a basically charged domain preceding a`helix-span-helix' motif located in the C-terminus. This region is highly conserved between the three proteins (75 ± 85%) and all bind to the GCCNNNGGC motif (Bosher et al., 1996) . Functional AP-2 binding sites exist in the enhancer regions of many genes including c-erbB-2/HER2 and cerbB-3/HER3, TGF-alpha and c-Kit, MCAM/MUC18 and AP-2a (Mitchell et al., 1987; Lee et al., 1987; Bosher et al., 1996; Skinner and Hurst 1993; Wang et al., 1997; Bar-Eli, 1997; Bauer et al., 1994) . In situ hybridization studies of murine embryos revealed that all three AP-2 genes are coexpressed in neural crest cells and their major derivatives, particularly in the central and peripheral nervous system as well in limb buds and epidermal, facial and urogenital tissues (Mitchell et al., 1991; Chazaud et al., 1996; Moser et al., 1997) . These observations suggested a role for AP-2 in the regulation of neural and epithelial gene expression during development. This was con®rmed by generating mice containing a homozygous disruption of the AP-2a or AP-2b gene. Histopathological examination of AP-2a null mice revealed severe abnormalities, particularly anencephaly, cranofacial defects, failure to close the ventral body wall, causing perinatal death (Schorle et al., 1996; Zhang et al., 1996) . AP-2b null mice exhibit enhanced apoptotic cell death of renal epithelial cells and die by postnatal day 1 and 2 because of polycystic kidney disease (Moser et al., 1997) .
AP-2 has also been associated with ras-induced cellular transformation of PA-1 cells, a human teratocarcinoma cell line. Overexpression of AP-2 in PA-1 cells leads to anchorage independent growth (Kannan et al., 1994) . Furthermore, there is a correlation between AP-2 expression and elevated levels of erbB2 protein in human breast cancer cells (Bosher et al., 1995) . In addition, childhood medullablastoma tumors (also termed central cerebellar primitive neuroectodermal tumor) reveal an association between AP-2 expression and the expression of cerbB-2, c-erbB-3 and also c-erbB-4 (Gilbertson et al., 1997) . However, recently it was shown that loss of AP-2 expression rather than overexpression might be a crucial event in the progression of human melanoma (Bar-Eli, 1997) .
Despite the accumulating data about the role of AP-2 during development and dierentiation, it is not clear in which speci®c aspects AP-2 plays a role. We have therefore elected to study the role of AP-2 in Drosophila, oering a much better de®ned system than mammals and a variety of genetic approaches.
Here we describe the identi®cation of a Drosophila orthologue of the AP-2 transcription factor family designated Drosophila AP-2 (DAP-2). DAP-2, like its vertebrate counterparts, exhibits a conserved modular protein structure: activation and DNA binding and dimerization domain. We ®nd that DAP-2 expression, ®rst observed at stage 9 during embryogenesis, is strikingly tissue speci®c throughout the embryonic development. We further provide data demonstrating that DAP-2 binds to the GCCNNNGGC AP-2 consensus binding site and activates transcription by binding to these sites in a manner that is similar to vertebrate AP-2 protein.
Results

Cloning of Drosophila AP-2
To search for an AP-2 gene in Drosophila, genomic DNA was used as a template for PCR ampli®cation. Ampli®cation was performed with degenerate primers derived from the ®rst helix domain and the preceding basically charged region of hAP-2a (Figure 1b) . A DNA fragment of 117 bp was cloned and found to match the hAP-2a sequence on the amino acid level in 17 of 18 positions between the primers. This fragment was then used to isolate genomic clones from a a Drosophila transcription factor AP-2 R Bauer et al Drosophila l phage library. A genomic 6-kb EcoRI fragment that hybridized to the 117 bp probe was then used to probe a lgt11 cDNA library prepared from embryos between 9 and 12 h of development. Seven cDNA clones were recovered; the largest, measuring 2181 bp (GenBank accession no: AF033030), is displayed in Figure 1a . The predicted protein start was identi®ed at position 411. As shown in Figure 1 the ATG at position 411 is preceded by a stop codon and sequences around the ®rst ATG perfectly match b Figure 1 (a) Sequence of the DAP-2 cDNA. The 2.2-kb cDNA contains an open reading frame of 465 amino acids. The sequence surrounding the ®rst ATG is in good match with the Drosophila consensus for translational initiation (Cavener, 1987) . The DAP-2 initiation and termination codons and the polyadenylation signal sequence are printed in bold letters. The amino acid stretch that is highly conserved between DAP-2 and vertebrate AP-2 is underlined. The bold italic printed letters mark the position of the hypothetical a-helices of the DNA binding/dimerization domain. (b) Comparison of the hAP-2 proteins AP-2a, b and g with DAP-2. The amino acids in the consensus line that are identical between the AP-2 proteins are marked with asterisks (*). Conservative amino acid changes are marked with dots (.). Dashes were introduced to preserve sequence overlap. Degenerate primers used for PCR are printed in bold letters and underlined. Triangles represent splice sites in hAP-2a (!) and DAP-2 (~) the Drosophila consensus sequence¯anking the translational start site (Cavener, 1987) . The ®rst inframe stop codon is found at position 1806, and the ®rst polyadenylation signal at position 1887. Starting with the ATG at position 411, this results in an open reading frame of 465 amino acids¯anked by a 5' untranslated sequence of 410 bp and a 3' untranslated sequence of 372 bp. A comparison of the putative DAP-2 with Xenopus AP-2 (XAP-2), mouse and human AP-2 proteins (mAP-2, hAP-2) revealed an overall identity of 42 ± 45% relative to the vertebrate AP-2 proteins at the amino acid level. However, within the DNA binding and dimerization domain (amino acids 238 ± 345) the homology increases to 92%. The AP-2 proteins possess two functional modules: activation and DNA binding/dimerization, located at the Nterminus and C-terminus of the protein, respectively. The N-terminal region of DAP-2 harboring the activation domain exhibits only 27 ± 30% identity to the N-terminal region of the vertebrate AP-2 proteins. Like the activation domain of the vertebrate AP-2 proteins the putative DAP-2 activation domain is also rich in proline and glutamine residues, primarily between amino acid 75 and 112. Interestingly, a small Figure 2 Comparison of the intron-exon structure of hAP-2a and DAP-2 showing the relative positions of all exons encoding hAP2a and DAP-2 proteins. The gap between exons 2 and 3 in hAP-2aA was introduced to allow better alignment. To look for similarities the activation and the helix-span-helix domain of hAP-2aA were compared to the corresponding regions of DAP-2 (Mount, 1993) are underlined. The sizes of the ®rst and the last exons, marked by an asterisk, refer to coding residues only motif`DFQPPYFPPP' (Figure 1b) within the activation domain that is conserved throughout the AP-2 transcription factor family is also found in Drosophila.
A hypothetical helix span helix motif in the Cterminal half of the AP-2 protein was identi®ed previously to mediate DNA-binding and dimerization (Williams and Tjian, 1991) . The helix span helix motif is conserved in the putative DAP-2 protein. As displayed in Figure 1b the region from amino acids 239 ± 345 containing the ®rst helix is highly conserved (92% identity). In contrast the more C-terminal region harboring the second part of the DNA binding motif (amino acids 246 to 465) shows only a low degree of identity (39%). However six of the 14 amino acid exchanges within that region are conservative changes (Figure 1b) . On the basis of the observation of a very high regional homology, we concluded that we have cloned the true Drosophila homologue of the mammalian AP-2 genes.
Intron-exon structure of DAP-2 Vertebrate AP-2 genes share a conserved modular structure in which speci®c functional domains are organized into certain speci®c exons. To determine if this organization is conserved in Drosophila we analysed the genomic phage clones derived by screening a Drosophila genomic library. We identi®ed a 24 kb genomic region containing the complete DAP-2 gene and identi®ed its intron-exon structure (see Table 1 and Figure 2 ). The mature DAP-2 mRNA is formed from eight exons. Some splice site positions were found to be in positions identical to that of human AP-2 genes. However, signi®cant divergences were also found in DAP-2 that correspond to the degree of conservation in the protein. For instance, sequences encoding the somewhat divergent activation domain of DAP-2 are split among three separate exons while in the hAP-2a gene the sequences encoding the same region are entirely contained within exon two. In addition, an intron located between exons 5 and 6 of the hAP-2a gene is missing from DAP-2. Interestingly, the alternative hAP-2aB mRNA, which is a dominant negative regulator of hAP-2 (Buettner et al., 1993) , is generated by failure to splice after the ®fth exon. Thereby a continuous transcript is processed that encodes for an alternative C-terminal open reading frame (Bauer et al., 1994) . Based on this we suggest that either Drosophila does not produce this isoform of AP-2 or does so by another mechanism.
Chromosomal mapping of DAP-2
To map DAP-2 to a speci®c chromosomal locus, squashes prepared from the salivary glands of third instar Drosophila larvae were hybridized with a digoxygenin-labeled genomic 6-kb DAP-2 DNA fragment. A positive signal was detected on chromosome 3 in region 79 A (Figure 3 ). To verify this result, cosmid clones covering the region of 79 A (kindly provided by the European Genome Mapping Project, Foundation of Research and Technology-Hellas) were tested for hybridization with the same probe used for polytene squash hybridizations. A 6-kb EcoRI band comigrating EMSAs were performed using either a 32 P-labeled oligonucleotides containing an AP-2a-622 site or a hMtIIa 7180 site together with 5 ml of in vitro translation lysate. A 50-fold excess of unlabeled wild-type or mutated oligonucleotide was used for competition. As a control, pCMXpL1 vector, which contained no insert, was translated in vitro (lysate) with that observed in DAP-2 bacteriophage clones was detected on the cosmid clone 23B2, thus con®rming the chromosomal location.
DNA-binding properties
The C-terminal region between amino acids 240 and 465 of DAP-2 is the most conserved region of the proteins and contains the AP-2 DNA-binding and dimerization domain. To test whether DAP-2 binds speci®cally to known human AP-2 consensus binding sites, the DAP-2 cDNA was translated in vitro and used in electromobility shift assays (EMSA). Two in vitro-translated DAP-2 products were detected (47 kDa and 55 kDa; Figure 4a ), consistent with the positions of ATG codons at nucleotides 411 and 609 as translational start sites ( Figure 1a) . The ATG at position 609 is probably used because its surrounding sequence matches the vertebrate transcriptional start site (Kozak, 1984) . However, it is not known whether this start site is used in Drosophila.
For EMSAs oligonucleotides were synthesized that match the AP-2 binding sites within the AP-2a gene promoter from residues 7632 to 7605 (AP-2a-622) or the human metallothionein IIa gene promoter from residues 7191 to 7164 (hMtIIa-180). Both sites have been shown to bind speci®cally hAP-2a, b and g (Bauer et al., 1994; Moser et al., 1995; . The in vitro translated DAP-2 products shifted complexes with both of these AP-2 consensus binding sites (Figure 4b ). The speci®city of the binding was veri®ed by competing the shifted complex with a 50-fold excess of the unlabeled mutated oligonucleotide. Addition of unlabeled oligonucleotides containing a mutated AP-2 binding site did not aect binding (Figure 4b ). To exclude the possibility that the rabbit reticulocyte lysate might contain proteins that bind to the AP-2 sites, a pCMX expression plasmid not containing a DAP-2 cDNA insert was translated in vitro and used as a negative control. As shown in Figure 4b a shifted complex indicative of an interaction with AP-2 binding sites was not detected with unprogrammed lysates. These results indicate that the DAP-2 protein binds to the same AP-2 consensus binding sites that are recognized by the mammalian protein.
DAP-2 is a transcriptional activator
The N-terminal domain of DAP-2 shows the lowest degree of homology to the vertebrate AP-2 proteins. However, the vertebrate AP-2 and the DAP-2 Nterminal regions share high contents of proline and glutamine residues (DAP-2 amino acids 74 ± 112). To determine whether DAP-2 can activate transcription, transfection experiments were carried out in 9117 cells, a PA-1 teratocarcinoma variant (Tainsky et al., 1988) , + mRNA was isolated and analysed by RT ± PCR for 25 cycles. Speci®c primers derived from exon 5 (sense) and exon 6 (antisense) were used to speci®cally amplify DAP-2. A genomic DAP-2 fragment was used as a control template and in Drosophila Schneider cells. The reporter constructs used in these experiments, AP-2a CAT2 and hMtIIaCAT2, contain a dimerized AP-2a 7622 and a trimerized hMtIIa 7180 AP-2 binding site, Schuetz, 1987) . Figure 5 shows that both reporter plasmids, AP-2a CAT2 and hMtIIaCAT2 have basal activity. Cotransfection of pCMXDAP-2 in 9117 cells enhanced the CAT activity signi®cantly (Figure 5a) . A similar result was observed in Drosophila Schneider cells (Figure 5b ) in which cotransfection experiments were carried out using a Drosophila actin 5C promoterdriven (Chung and Keller, 1990) DAP-2 expression plasmid, pActDAP-2. These experiments demonstrate that DAP-2 activates transcription in an AP-2 binding site-speci®c manner in both mammalian and Drosophila cell lines.
Expression of DAP-2 during Drosophila embryonic development
To analyse DAP-2 expression during embryonic development we investigated the presence of DAP-2 transcripts at dierent times of Drosophila development by performing RT ± PCR with DAP-2-speci®c primers annealing to exon 5 (sense) and exon 6 (antisense). A genomic DAP-2 DNA fragment was used as a control. PCR products of the predicted size ( Figure 6 ) were detected using mRNA derived from embryos, larvae and adult¯ies as a template, suggesting that DAP-2 is expressed in these stages.
We next analysed spatial and temporal DAP-2 expression during Drosophila embryogenesis by in situ hybridizations to whole-mount embryos. The earliest expression of DAP-2 occurs at stage 9 in the neuroectodermal territories of the head of the embryo (Figure 7a ). The procephalic neuroectoderm includes part of the intercalary, antennal, and labral/acron (or ocular) segments. The parts of the brain assigned to these head segments are called tritocerebrum (intercalary segment), deuterocerebrum (antennal segment), and protocerebrum (labral segment/acron or ocular segment; Figure 8 ). According to these assignments (Younossi-Hartenstein et al., 1996) , DAP-2 is expressed in the region of the central/posterior protocerebral domain (compare with Figure 8a ), which might include part of the region of the optic lobe placode because DAP-2 is expressed in the brain/optic lobe zone during later embryonic stages.
At stage 10, DAP-2 expression is additionally seen in the dorsomedial protocerebral domain (Figure 7b ). During late germ band extension (stage 11), segmentation of the embryo becomes evident. The gnathal lobes (mandibular, maxillary and labial) appear in the ventral region of the head. At that stage, the maxillary segment shows detectable DAP-2 expression ( Figure  7c) . Most of the DAP-2 expression is found in a region within the dorsomedial protocerebral domain. DAP-2 transcripts are also detected dorsal of the optic lobe primordium within the region of the posterior protocerebral domain (compare with Figure 8b ).
During germ band retraction (stage 12), DAP-2 is strongly expressed in a protocerebral domain which appears to be primordia for the eye-antennal disc and optic lobe (Figures 7d and 8c) . The expression in the region of the maxillary segment becomes very strong. DAP-2 transcripts are also detected in a patch of cells located above the mandibular segment in the region of the antennal lobe domain. Additionally DAP-2 expression is observed in cells of the ventral nerve cord for the ®rst time (Figure 7d ). The expression pattern in a subset of cells within the ventral nerve cord is very speci®c. Once the segmental furrows are completed, at the end of the germ band retraction, the DAP-2-expressing cells are located along the ventral nerve cord in each segment (Figure 7e and f) . At stage 14, during progressing head involution, DAP-2 expression is found in the antenno-maxillary complex which is maintained until late embryogenesis ( Figure  7g , h, j and l). DAP-2 transcripts are also detected within regions of the eye-antennal disc and the brain/ optic lobe zone in the posterior dorsal and lateral regions of the brain (Figure 7g and h) . A dorsal view of a stage-16 embryo shows DAP-2 expression around the wide internal lumen of the optic lobe and the adjacent brain (Figure 7j ). This pattern is still retained during very late embryogenesis (stage 17; Figure 7l ).
Discussion
Cloning and characterization of the transcription factor AP-2 in Drosophila
The mammalian AP-2 transcription factor family consists of three dierent isoforms; AP-2a, AP-2b and AP-2g (Williams et al., 1988; Moser et al., 1995; Chazaud et al., 1996) . The three proteins are transcribed from three dierent genes but reveal a consistent modular protein structure. This organization is also conserved in the Xenopus homologue of the AP-2 transcription factor (Winning et al., 1991) . Because of the high degree of homology among the vertebrate AP-2 proteins, we investigated the possible existence of a Drosophila homologue.
Comparison of sequences indicates that the activation domain of AP-2 is considerably more divergent between¯ies and vertebrates than is the DNA binding/ dimerization region. However, our functional experiments indicate that DAP-2 can activate transcription in human and Drosophila cells, suggesting that the sequences essential for the function of this domain have been conserved. Shared characteristics of the activation domain of AP-2 proteins include a high content of glutamine and proline as well as a short amino terminal amino acid sequence`DFQPPYFPPP' that is found in the activation domains of all AP-2 proteins so far examined. Interestingly, the dierences between the DAP-2 and the hAP-2a protein within the N-terminal activation domain are also re¯ected on the level of the intron-exon structure (Figure 2 ), suggesting that divergence in protein sequence and gene structure occur in the same region. Notably, several N-terminal splice variants have been demonstrated for AP-2a in mice (Meier et al., 1995) .
Comparison of the sequence of Drosophila and human AP-2 proteins also suggests a speci®c region (DAP-2 amino acids 239 to 345) of the DNA binding domain that may be responsible for speci®c binding (Williams and Tjian, 1991) . Within the proposed basic helix-span-helix motif the N-terminal part of this motif (basic and ®rst helix region; 92% identity) is much better conserved than the downstream regions (span and second helix region; 39% identity). DAP-2 binds speci®cally to vertebrate AP-2 consensus binding sites (Figure 4b) , and minimal base changes in the consensus binding site eliminate the ability of sequences to compete for binding. Due to its relative conservation we believe that a 107 amino acid region may provide the DNA binding speci®city.
An interesting dierence between the DAP-2 and the hAP-2a gene in the intron-exon structure is observed in the C-terminal portion of these genes. A failure to splice at the splice site between exons 5 and 6 of the hAP-a gene results in hAP-2aB, a dominant negative form of hAP-2a (Buettner et al., 1993; Bauer et al., 1994) . Thus, the AP-2aB protein, made from AP-2a apparently required a dierent exon organization, which may re¯ect a function acquired during evolution.
The ®nding of only a single AP-2 gene in Drosophila, while several exist in mammals, suggests the possibility that AP-2 has undergone gene duplication events subsequent to divergence of¯ies and mammals. The three dierent AP-2 genes are strongly coexpressed in neural crest cells, but analysis of AP-2a-and AP-2b-null mice led to the conclusion that the function of the genes during embryonic development diers considerably (Moser et al., 1997) , indicating that after the proposed gene duplication (Holland et al., 1994 ) the functions of these proteins were expanded.
Expression of DAP-2 during Drosophila embryonic development and possible functional implications
To determine the spatial and temporal expression pattern of DAP-2 in Drosophila we analysed the distribution of DAP-2 in the developing embryo. Our whole-mount in situ hybridization data revealed that DAP-2 expression starts at stage 9, when the ®rst wave of neuroblasts also start to delaminate from the ectoderm. During stages 10 and 11 (Figure 7 ) DAP-2 expression in distinct regions of the embryonic head becomes more prominent. DAP-2 expression is detected in a subset of cells within the ventral nerve cord (vnc) before neuronal dierentiation starts at stage 13 and after neuroblast delamination is accomplished. Judging from the pattern of gene expression, a major function of DAP-2 might be in the development and dierentiation of the brain and the central nervous system.
In situ hybridization in mice revealed a distinct but partially overlapping AP-2 expression pattern of all three mAP-2 genes in regions of the developing brain (Mitchell et al., 1991; Chauzaud et al., 1996; Moser et al., 1997) . This suggests a possible conserved role for AP-2 in the development and dierentiation of CNS tissues. Several examples of transcription factors that play conserved roles in neuronal dierentiation are known (Treier et al., 1995; Jan and Jan, 1994) .
While we have yet to determine the functions carried out by DAP-2 in the Drosophila CNS, the patterns of its expression we have observed during embryonic development, have interesting parallels to the expression and function of AP-2 in mouse embryogenesis. Consistent with the expression pattern of DAP-2 within regions of the Drosophila visual system, namely the optic lobe, are observations that were made in mammals. AP-2 expression during mouse embryogenesis was observed around the eye in areas of developing neuroepithelial sensory structures (Mitchell et al., 1991 Moser et al., 1995 , and AP-2a null mice exhibit a displaced optic cup with dysmorphic neural and pigmented retinal layers of the eye developing medially (Schorle et al., 1996) . Recently, it was shown that AP-2 is a regulator of the retinal fatty-acid-binding protein, which is involved in the retinal maturation process (Bisgrove et al., 1997) . DAP-2 expression within the region of the brain/optical lobe zone raises the question whether AP-2 is also involved in the development of the visual system.
With the beginning of head involution, the antennomaxillary complex (Figure 7) , a region giving rise to head structures, shows strong DAP-2 expression. During mouse embryogenesis, AP-2a, AP-2b and AP2g are expressed strongly in the neural crest cells, which also participate in the formation of many vertebrate head structures (Hall, 1988) . AP-2a null mice die perinatally with cranio-abdominoschisis and severe dismorphogenesis of the face, skull, and sensory organs (Schorle et al., 1996; Zhang et al., 1996) .
During stage 12, DAP-2 expression becomes evident in a protocerebral domain, which appears to be primordia for the eye-antennal disc and the optic lobe (Figure 7) . Much of the adult head capsule is derived from the fusion of the paired eye-antennal disc. The Deformed gene, which functions in the speci®cation of regions of the head capsule (Lewis et al., 1980) , is a homologue of the mouse Hox A4 gene, which is a known target of AP-2 transcriptional activation (Doerksen et al., 1996) .
In summary, our ®ndings provide a means to investigate the function of AP-2 during development and dierentiation in a well understood genetic system. Genetic analyses will allow us to investigate the cell and tissue speci®c function of AP-2 as well as to test the possibility that AP-2 functions in signaling by ras pathways as has been suggested (Buettner et al., 1991; Kannan et al., 1994) . Already existing mutations in genes aecting head and CNS development will provide helpful information on the developmental role of DAP-2. Therefore, the studying of the AP-2 gene in Drosophila may lead to a better understanding of its function and of the consequences of both gain and loss of function.
Material and methods
Isolation of a clone encoding DAP-2
Degenerate primers were designed from sequences within the human AP-2a (hAP-2a) ®fth exon (AP-2a sense: 5'-GCNAAGTCNAAGAACGGNGGNAGGTCNTTN-3', AP-2a antisense: 5'-CTCNACNAGNGANGTNAGNA-NNGTNACGTT-3'). These polymerase chain reaction (PCR) primers correspond to residues at position 1326 ± 1361 and 1413± 1439 of the DAP-2 cDNA. Genomic Drosophila DNA (1mg) was used as a template for PCR ampli®cation. A single 117-bp PCR ampli®cation product was cloned into pBluescript pBS SK II 7 (Stratagene) and sequenced.
This DNA fragment was then used to screen a Drosophila genomic library in bacteriophage vector Charon 4 (Maniatis et al., 1978; kindly provided by Ben Zion Shilo, Weizmann Institute, Rehovot, Israel) . Approximately 60 000 phage plaques were plated at density of 15 000 plaques per plate (150 mm). All hybridizations were performed under stringent conditions of 658C with ®nal washes in 0.26SSC according standard protocols (Maniatis et al., 1989) . Eight positive hybridization plaques visualized by autoradiography were picked and puri®ed. l DNA was prepared from plaquepuri®ed clones, digested with EcoRI and subcloned into the pBS SK II 7 vector sequenced. Seven of these clones contained sequences of the PCR product.
To isolate a full-length cDNA clone, one genomic DAP-2 fragment in pBS SK II7was used to screen a lgt11 cDNA library prepared from embryos between 9 and 12 h of development (kindly provided by Kai Zinn, California Institute of Technology, Pasadena, CA, USA). For this purpose about 400 000 l plaques were plated at a density of 30 000 plaques per plate (150 mm). Hybridization conditions were the same as described above. Seven positive plaques were identi®ed, digested with EcoRI and subcloned in pBS SK II
7
. The longest clone was sequenced entirely.
Chromosomal mapping
Polytene chromosome squashes were prepared from the salivary glands of third instar Drosophila larvae. The slides were washed for 20 min in 26SSC at 688C, dehydrated twice for 5 min in fresh changes of 70% ethanol and for another 5 min in 95% ethanol and air dried. The squashes were denatured in 0.07 M NaOH at room temperature for 3 min, then washed three times with 26SSC for 5 min and dehydrated as described. Each squash was hybridized at 538C for 12 to 15 h with a biotinylated genomic 6-kb DAP-2 DNA-fragment in 27 ml of hybridization solution (50% formamide, 56SSC, 100 mg/ml denatured salmon sperm DNA, 0.1% Tween 20 and 3 ml of the probe). The excess probe was washed o with PBS containing 0.1% Tween (PBT) for 365 min at 538C. Following the incubation of the squashes with alkaline phosphatase-conjugated anti DIG antibody for 1 h at room temperature, the slides were washed with PBT, as described above, at room temperature and rinsed in alkaline phosphatase buer. The hybridization was visualized with a NBT ± BCIP staining solution (Boehringer, Mannheim) following the chromosome staining with Giemsa in PBS.
In situ hybridization
For in situ hybridization, digoxygenin-labeled RNA sense or antisense probes were generated by in vitro transcription of an N-terminal EcoRI fragment from the DAP-2 fulllength cDNA subcloned in the pBluescript vector (Stratagene) according to the manufacturer's instructions (Boehringer Mannheim). The in vitro transcribed product was hydrolyzed for 40 min at 658C in 60 mM Na 2 CO 3 and 40 mM NaHCO 3 , pH 10, and precipitated with 0.4 M LiCl and 3 vol of ethanol. The ®nal RNA products were resuspended in 50 ml DEPC-treated H 2 O and frozen at 7808C until used. Antisense and sense probes were generated from the same template simultaneously and used under identical conditions in parallel.
Whole-mount in situ hybridization of Drosophila embryos was prepared essentially according to the protocol of Lehmann and Tautz (1994) . Brie¯y, after dechorionation and ®xation, the embryos were treated with proteinase K (40 mg/ml) for 4.5 min and then extensively washed in fresh changes of DEPBT buer (PBS with 0.1% diethylpyrocarbonate). The temperature was maintained at 558C during hybridization and washing. The embryos were dehydrated in series with ethanol and mounted in methyl salicylate: Canada balsam.
Isolation and reverse transcription-PCR (RT ± PCR) analysis of RNA
Whole Drosophila embryos, larvae, and¯ies were homogenized in a 26NETS/phenol (1 : 1) solution (200 mM NaCl; 2 mM EDTA; 20 mM Tris, pH 8 and 1% SDS) and total RNA was extracted (Mattox et al., 1990) . Oligo d(T) cellulose chromatography was performed twice using commercially available spin columns (Pharmacia Biotech Inc.).
For RT ± PCR analysis 0.5 mg of DNase I-treated poly (A) + RNA was reverse transcribed by using 25 U of Avian murine virus reverse transcriptase (Boehringer, Mannheim) with a DAP-2-speci®c antisense primer. The reaction mixture contained poly (A) + RNA, 56reverse transcriptase buer provided by the manufacturer, 35 U of RNase inhibitor (Pharmacia Biotech. Inc), and 0.2 mM of deoxynucleoside triphosphates (dNTP) in a ®nal volume of 30 ml. The mixture was heated to 658C for 5 min. AMV reverse transcriptase was added and the mixture was incubated at 428C for 60 min. After the completion of the ®rst-strand cDNA synthesis, 1/10 of the reaction volume was ampli®ed directly by using 5 U of Taq polymerase and 5 mM of DAP-2-speci®c sense and antisense primers located on exon 4 and exon 5 of DAP-2 (DAP-2 sense exon 4: 5'-GAGCACCTC-GAAATACAAGGTCACCATAG-3', DAP-2 antisense exon 5:
5'-TTCGGTTTCGCAAACGAAGTGAAAGTCC-3'). PCR was performed in a ®nal volume of 100 ml by incubating cDNA and primer in a buer containing 1.75 mM Mg 2 Cl and 0.2 mM dNTPs. PCR conditions were 2 min at 948C and then 25 cycles of 1 min at 948C, 1 min at 608C, 1.5 min at 728C, followed by 5 min at 728C. The predicted PCR product was 269 bp. Using genomic Drosophila DNA as a control, the ampli®cation product resulted in a 328 bp fragment.
In vitro translation
Full-length DAP-2 cDNA was cloned into pCMXpL1 (pCMXDAP-2) expression plasmid. Linearized DNA (1 mg) from the pCMXDAP-2 expression vector was transcribed and translated at 308C for 2 h in a 50-ml mixture using a TNT R -coupled rabbit reticulocyte lysate (Promega) according to the manufacturer's instructions. The in vitro translated products were separated by SDS gel electrophoresis in a 12.5% SDS polyacrylamide gel. The gel was dried and analysed by autoradiography. DAP-2 in vitro translation products were used for electromobility shift assays (EMSAs).
Gel mobility shift assays
As probes for EMSAs oligonucleotides were annealed with their complementary strand and 32 P-labeled at their ends by Klenow ®ll-in reaction. The following oligonucleotides were used for EMSA: AP-2a-622 site: 5'-AGTA-GAAGCTGGGCCCCAGGCGTGGCGCTT-3' and hMtIIa-180 site: 5'-AGGAACTGACCGCCCGCGGCC-CGTGTGCAGAG-3'. A total of 2.5610 4 c.p.m. of the labeled double-stranded oligonucleotide was incubated with in vitro translated DAP-2 protein in 10 mM HEPES, pH 7.5; 25 mM DTT; 50 mM KCl; 6 mM Mg 2 Cl; 100 mg/ml BSA; and 1 mg poly (dI-dC) at 308C for 30 min. The unlabeled wild-type oligonucleotide probes or the mutant AP-2a-622 site and hMtIIa-180 site were used in 50-fold excess as a competitor for binding to demonstrate binding speci®city to the AP-2 sites: AP-2a-622 mutant site: 5'-AGTAGAAGCTGGGAAACAGGCGTGGCGCTT-3' and hMtIIa-180 mutant site: 5'-AGGAACTGACC-GACCGCTGCCCGTGTGCAGAG-3' (mutated nucleotides are printed as bold letters). The DNA/protein complexes were analysed by gel electrophoresis (5% polyacrylamide gel).
Transfection and chloramphenicol-transacetylase-assays
For transient expression of DAP-2 in mammalian cells and Drosophila Schneider cells, full-length DAP-2 cDNA was cloned in sense orientation downstream of CMV (Umesono et al., 1991) or a Drosophila actin 5C promoter (Chung and Keller, 1990) . These constructs are referred to here as pCMXDAP-2 and pActDAP-2. To measure the DAP-2 transcription activity a reporter plasmid was constructed by dimerization of an AP-2 response element of the hAP2a promoter corresponding to nucleotides 7632 to 605 (Bauer et al., 1994) and then cloning it in front of a herpes simplex virus promoter in the vector pBLCAT2 (Luckow and Schuetz, 1987) . We refer to this construct as AP-2-622 CAT. AP-2hMtII CAT contains a trimerized hMtIIa 7180 site in front of a minimal TK promoter and is described elsewhere (Buettner et al., 1993; Kannan et al., 1994) . Transient transfection of the PA-1 human teratocarcinoma cell line clone 9117 (Buettner et al., 1991 : Tainsky et al., 1988 was performed using calcium phosphate precipitations (Graham and van der Eb, 1973) . Drosophila Schneider cells were transfected using 25 ml of CellFectin (Gibco ± BRL) according to the manufacturer's instructions. A total of 3 mg of reporter plasmid was used in transfections and 0.5 mg of the DAP-2 expression plasmid was used in cotransfection experiments. CAT assays were performed using equal amounts of protein extracts for 90 min in the presence of 14 C chloramphenicol and 80 mg of acetyl CoA. Acetylated forms of chloramphenicol were separated on TLC plates (Gorman et al., 1982) . All CAT assays were repeated at least three times.
